Inozyme Pharma Stock (NASDAQ: INZY) stock price, news, charts, stock research, profile.
Open | $4.52 |
Close | $4.60 |
Volume / Avg. | 287.55K / 485.41K |
Day Range | 4.52 - 4.70 |
52 Wk Range | 2.69 - 7.80 |
Market Cap | $284.54M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 4.78% |
Days to Cover | 10.68 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inozyme Pharma (NASDAQ:INZY) through any online brokerage.
Other companies in Inozyme Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Renovaro (NASDAQ:RENB), Tectonic Therapeutic (NASDAQ:TECX), Zentalis Pharma (NASDAQ:ZNTL) and Inovio Pharmaceuticals (NASDAQ:INO).
There is no analysis for Inozyme Pharma.
Inozyme Pharma has a consensus price target of $14.33.
The stock price for Inozyme Pharma (NASDAQ: INZY) is $4.6 last updated Today at July 8, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Inozyme Pharma.
Inozyme Pharma’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Inozyme Pharma.
Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.